Over 15 years of ELTEC: A report of the international BFM study group

Pediatr Blood Cancer. 2007 Jul;49(1):113-4; discussion 112. doi: 10.1002/pbc.21087.

Authors

M Paulides¹, R Haupt, M Jankovic, A Möricke, T Langer, J D Beck; ELTEC GroupELTEC members: E. Frey, H. Lackner, A. Moser, Austria; R. Maurus, J. Otten, P. Philippet, Belgium; J.D. Beck, G. Calaminus, H.G. Dörr, T. Langer, A. Möricke, M. Paulides, T. Rau, Germany; M.M. Hawkins, A. Taylor, Great Britain; E. Magyarosy, Hungary; E. Castagnola, A. Colombini, F. Fioredda, R. Haupt (Chairman), M. Jankovic, C. Manganini (Secretary), C. Micalizzi, P. Reciputo, M.G. Valsecchi, Italy; J.P.M. Bökkerink, W. Tissing, The Netherlands; A. Feldges, J. Greiner, Swit

Affiliation

¹ Late Effects Surveillance System, University Hospital for Children and Adolescents, Erlangen, Germany.

PMID: 17066469
DOI: 10.1002/pbc.21087

No abstract available

Publication types

Congress

MeSH terms

Antineoplastic Agents / adverse effects*
Brain Diseases / chemically induced*
Child
Child, Preschool
Hepatitis C / etiology*
Humans
Leukemia / drug therapy*

Substances

Antineoplastic Agents